Trial Profile
PET Whole Body Biodistribution Using Florbetapir (18F)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 17 Oct 2014 New trial record